Vinati Organics Limited (VINATIORGA) Latest Updates

Recent Financial Performance (Q3 FY26) In the quarter ended December 2025 (Q3 FY26), the company reported a consolidated net profit of ₹100.83 crore, a 7.6% increase compared to the same period last year, but a sequential decline of 12.2% from Q2 FY26. Consolidated revenue for the quarter stood at ₹530.78 crore, showing a marginal year-on-year growth of 1.7%. EBITDA margins stood at approximately 30%, supported by lower input costs despite muted demand in certain segments. Capacity Expansion & New Products The company recently commercialized an additional 10,000 MTPA capacity for ATBS (its flagship high-margin product) during Q3 FY26, with Phase II expansion scheduled for commissioning in Q1 FY27. Furthermore, new plants for products like 4MAP, TAA, and PTAP were slated to become operational by the end of Q4 FY26. Commercial revenue from new specialty chemicals like MEHQ and Guaiacol is expected to begin in FY27 following current customer approval phases. Subsidiary InvestmentsIn March 2026, Vinati Organics made a significant additional investment of ₹22.95 crore in its wholly-owned subsidiary, Veeral Organics Private Limited, through a rights issue. This capital infusion is intended to support the subsidiary's focus on manufacturing organic fine specialty chemicals, which saw its turnover grow from near zero to over ₹10 crore in the last financial year. Market Data & Upcoming Events The stock recently hit a 52-week low of ₹1,249 in early April 2026 amidst a broader sell-off in the chemicals sector and macro concerns regarding global tariffs. The Board of Directors is expected to meet in May 2026 to approve the audited financial results for the full year (FY26) and consider a final dividend recommendation for shareholders.